New Feature

we need to complete weekly stock takes on controlled medication. we currently write this in the cd book which for those that have JIC meds prescribed but not administered yet it is take up pages of weekly stock takes

It would be a valuable improvement if ATLAS eMAR could store and display completed PRN medication assessments that result in a decision not to administer the medication. Currently, while the system records when PRN medication is administered and l...

During a CQC inspection, I was asked to show the inspector how many missed records we had in the last 30 days and evidence of action taken. I was unable to do this. It would be extremely beneficial if we had a report that could report on any misse...

Hello Can we have a alert raised when booking a medication with new schedule, often rooting from pharmacy side when they times changed, the book in person can get an alert that the medication schedule has changed , can we have this feature in atla...

There currently isn't a way to be able to add changing doses on the system - it isn't a variable dose as the dose is set as 2 tablets one day, three tablets the next day and following this routine on alternate days. Currently you have to set this ...

The GP's often change wording or dosing for medications and then require new prescriptions to be ordered. When returning stock it would be useful to have a drug changed option on the drop down instead of selecting drug stopped/extra.. etc

to add a warning for control drug, and not allow self witness for control drug

Due to a recent medication incident it would be beneficial for eyedrops, eardrops inhalers etc to have a accurate stock check instead of no stock control.

On reviewing the stock take report it doesn't define if there have been any stock discrepancies and only produces the current stock total. Having the stock discrepancies report would help define where there have been issues during the monthly cycl...

Introduce a dedicated Topical MAR chart specifically for body creams and lotions, separate from medication MARs, to improve clarity, compliance, and auditing. This chart would sit alongside the existing Reports → Topical MAR but be exclusively for...